emivirine has been researched along with Pregnancy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, E; Akpomiemie, G; Arulappan, N; Chandiwana, N; Chersich, M; Clayden, P; Fairlie, L; Hill, A; Masenya, M; Mashabane, N; McCann, K; Moorhouse, M; Norris, S; Qavi, A; Serenata, C; Simmons, B; Sokhela, S; Venter, WDF; Vos, A | 1 |
| Barry, DW; Blum, MR; Borroto-Esoda, K; Endoh, R; Furman, P; Grizzle, TB; Moxham, C; Niwa, T; Painter, GR; Sommadossi, J; Szczech, GM; Yamamoto, M | 1 |
1 trial(s) available for emivirine and Pregnancy
| Article | Year |
|---|---|
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Intention to Treat Analysis; Male; Middle Aged; Oxazines; Phosphorous Acids; Piperazines; Pregnancy; Pregnancy Complications, Infectious; Prodrugs; Pyridones; RNA, Viral; Uracil; Viral Load; Young Adult | 2019 |
1 other study(ies) available for emivirine and Pregnancy
| Article | Year |
|---|---|
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Bone Marrow; Dogs; Female; Fetus; Guinea Pigs; HIV-1; Humans; Liver; Macaca fascicularis; Male; Mice; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Uracil | 2000 |